2020-08-23 6. Room 202
時間主題
09:00 ~ 09:10
PD05-1: Factor evaluation of chemotherapy-naïve Enzalutamide on castration - resistant prostate cancer patients—Taiwanese cohort
講者: 余秉軒 座長: 張英勛,
林子平
09:10 ~ 09:20
PD05-2: Tumor volume, time to PSA nadir and PSA decline rate influence outcomes in metastatic prostate cancer receiving androgen deprivation therapy
講者: 林晏頎 座長: 張英勛,
林子平
09:20 ~ 09:30
PD05-3: Pathological node-positive renal cell carcinoma is associated with worse survival outcome: A recall for TMN staging revision
講者: 陳思遠 座長: 張英勛,
林子平
09:30 ~ 09:40
PD05-4: Active contour model of machine learning to evlauate the kidney cancer
講者: 盧致誠 座長: 張英勛,
林子平
09:40 ~ 09:50
PD05-5: The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: Systemic review and meta-analysis
講者: 謝博彥 座長: 張英勛,
林子平
09:50 ~ 10:00
PD05-6: Combined immune checkpoint inhibitors in the frontline treatment of metastatic renal cell carcinoma—a real-world experience
講者: 陳鵬 座長: 張英勛,
林子平